Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 3
2007 1
2008 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Clinical applications of virosomes in cancer immunotherapy.
Adamina M, Guller U, Bracci L, Heberer M, Spagnoli GC, Schumacher R. Adamina M, et al. Among authors: schumacher r. Expert Opin Biol Ther. 2006 Nov;6(11):1113-21. doi: 10.1517/14712598.6.11.1113. Expert Opin Biol Ther. 2006. PMID: 17049010 Review.
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.
Weber WP, Feder-Mengus C, Chiarugi A, Rosenthal R, Reschner A, Schumacher R, Zajac P, Misteli H, Frey DM, Oertli D, Heberer M, Spagnoli GC. Weber WP, et al. Among authors: schumacher r. Eur J Immunol. 2006 Feb;36(2):296-304. doi: 10.1002/eji.200535616. Eur J Immunol. 2006. PMID: 16385630 Free article.
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
Adamina M, Weber WP, Rosenthal R, Schumacher R, Zajac P, Guller U, Frey DM, Oertli D, Zuber M, Heberer M, Spagnoli GC. Adamina M, et al. Among authors: schumacher r. Contemp Clin Trials. 2008 Mar;29(2):165-81. doi: 10.1016/j.cct.2007.07.002. Epub 2007 Jul 17. Contemp Clin Trials. 2008. PMID: 17707139 Clinical Trial.
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.
Oertli D, Marti WR, Zajac P, Noppen C, Kocher T, Padovan E, Adamina M, Schumacher R, Harder F, Heberer M, Spagnoli GC. Oertli D, et al. Among authors: schumacher r. Hum Gene Ther. 2002 Mar 1;13(4):569-75. doi: 10.1089/10430340252809856. Hum Gene Ther. 2002. PMID: 11874634
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U, Adamina M, Bolli M, Weber WP, Zajac P, Groeper C, Reschner A, Feder C, Schumacher R, Marti W, Oertli D, Heberer M, Spagnoli GC. von Holzen U, et al. Among authors: schumacher r. Int J Cancer. 2005 Jun 10;115(2):248-55. doi: 10.1002/ijc.20858. Int J Cancer. 2005. PMID: 15688403
11 results